Johanna Junker

ORCID: 0000-0003-0756-9569
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Botulinum Toxin and Related Neurological Disorders
  • Parkinson's Disease Mechanisms and Treatments
  • Neurological disorders and treatments
  • Neurological diseases and metabolism
  • Genomics and Rare Diseases
  • Genetic Neurodegenerative Diseases
  • CRISPR and Genetic Engineering
  • Autism Spectrum Disorder Research
  • Nuclear Receptors and Signaling
  • Cerebral Palsy and Movement Disorders
  • Lysosomal Storage Disorders Research
  • Acupuncture Treatment Research Studies
  • Neurogenetic and Muscular Disorders Research
  • Neuroscience and Music Perception
  • Genetics and Neurodevelopmental Disorders
  • Mitochondrial Function and Pathology
  • Terrorism, Counterterrorism, and Political Violence
  • Healthcare Decision-Making and Restraints
  • Motor Control and Adaptation
  • Hereditary Neurological Disorders
  • Genetic Associations and Epidemiology
  • Tactile and Sensory Interactions
  • Complementary and Alternative Medicine Studies
  • Vestibular and auditory disorders
  • Pediatric Pain Management Techniques

University of Lübeck
2017-2025

University Hospital Schleswig-Holstein
2017-2024

The Neurological Institute
2020

Louis Stokes Cleveland VA Medical Center
2020

Sorbonne Université
2018

University of Colorado Anschutz Medical Campus
2018

University of Tennessee Health Science Center
2016

Emory University
2016

Vanderbilt University
2016

Vodafone Foundation
2010

Depression and anxiety frequently accompany the motor manifestations of isolated adult-onset focal dystonias. Whether body region affected when this type dystonia first presents is associated with severity these neuropsychiatric symptoms unknown.The aim study was to determine whether depression, social vary by onset site evaluate pain account for any differences.Patients evaluated within 5 years from symptom onset, enrolled in Natural History Project Dystonia Coalition, were included...

10.1136/jnnp-2016-315461 article EN cc-by-nc Journal of Neurology Neurosurgery & Psychiatry 2017-04-24

Objective Isolated focal dystonia can spread to muscles beyond the initially affected body region, but risk of has not been evaluated in a prospective manner. Furthermore, regions at for and clinical factors associated with are well characterised. We sought here prospectively characterise recently diagnosed adult-onset isolated patients. Methods Patients enrolled Dystonia Coalition affecting only neck, upper face, hand or larynx onset symptoms were included. Timing follow-up visits was based...

10.1136/jnnp-2019-321794 article EN cc-by-nc Journal of Neurology Neurosurgery & Psychiatry 2019-12-17

To assess the clinical manifestations and predictors of different types tremors in individuals with isolated dystonia.Clinical tremor were assessed a multicenter, international cross-sectional, cohort study 2,362 all dystonia (focal, segmental, multifocal, generalized) recruited through Dystonia Coalition.Methodical standardized assessments participants this revealed overall prevalence any type was 53.3%. The dystonic varied from 36.9% to 48.4%, depending on criteria used define it. identify...

10.1212/wnl.0000000000011049 article EN Neurology 2020-10-13

The Monogenic Network of the Global Parkinson's Genetics Program (GP2) aims to create an efficient infrastructure accelerate identification novel genetic causes disease (PD) and improve our understanding already identified causes, such as reduced penetrance variable clinical expressivity known disease-causing variants. We aim perform short- long-read whole-genome sequencing for up 10,000 patients with parkinsonism. Important features this project are global involvement focusing on...

10.1038/s41531-023-00526-9 article EN cc-by npj Parkinson s Disease 2023-06-27
Clodagh Towns Madeleine Richer Simona Jasaityte Eleanor J. Stafford Julie Joubert and 95 more Tarek Antar Alejandro Martínez-Carrasco Mary B. Makarious Bradford Casey Dan Vitale Kristin Levine Hampton L. Leonard Caroline B. Pantazis Laurel A. Screven Dena Hernández Claire Wegel Justin Solle Mike A. Nalls Cornelis Blauwendraat Andrew Singleton Manuela Tan Hirotaka Iwaki Huw R. Morris Emilia Gatto Marcelo Kauffman Samson Khachatryan Zaruhi Tavadyan Claire E. Shepherd Julie Hunter Kishore R. Kumar Melina Ellis Miguel E. Rentería Sulev Kõks Alexander Zimprich Artur Francisco Schumacher Schuh Carlos Roberto de Mello Rieder Paula Saffie Awad Vítor Tumas Sarah Camargos Edward A. Fon Oury Monchi Ted Fon Benjamin Pizarro Galleguillos Marcelo Miranda M. Leonor Bustamante Patricio Olguı́n Pedro Chaná Beisha Tang Huifang Shang Jifeng Guo Piu Chan Wei Luo Gonzálo Arboleda Jorge Orozco Marlene Jiménez-Del-Río Álvaro Hernández-Flores Mohamed Salama Walaa A. Kamel Yared Z. Zewde Alexis Brice Jean‐Christophe Corvol Ana Westenberger Anastasia Illarionova Brit Mollenhauer Christine Klein Eva‐Juliane Vollstedt Franziska Hopfner Günter U. Höglinger Harutyun Madoev Joanne Trinh Johanna Junker Katja Lohmann Lara M. Lange Manu Sharma Sergiu Groppa Thomas Gasser Zih‐Hua Fang Albert Akpalu Georgia Xiromerisiou Georgios Hadjigorgiou Ioannis E. Dagklis Ioannis Tarnanas Leonidas Stefanis María Stamelou Efthymios Dadiotis Alex Medina Germaine Hiu-Fai Chan Nancy Y. Ip Nelson Yuk-Fai Cheung Phillip Chan Xiaopu Zhou Asha Kishore Divya KP Pramod Kumar Pal Prashanth Lingappa Kukkle Roopa Rajan Rupam Borgohain Mehri Salari Andrea Quattrone Enza Maria Valente

The Global Parkinson's Genetics Program (GP2) will genotype over 150,000 participants from around the world, and integrate genetic clinical data for use in large-scale analyses to dramatically expand our understanding of architecture PD. This report details workflow cohort integration into complex arm GP2, together with outline monogenic hub a companion paper, provides generalizable blueprint establishing large scale collaborative research consortia.

10.1038/s41531-023-00533-w article EN cc-by npj Parkinson s Disease 2023-09-12
Sarah Pirio Richardson Ashley Wegele Betty Skipper Amanda Deligtisch Hyder A. Jinnah and 95 more Ami Rosen Mark Hallett Vesper Fe Marie Jung M. Park Karin Mente Hyunjoo Cho Elaine Considine Alfredo Berardelli Gina Gerrazzano Scott A. Norris Joel S. Perlmutter Laura Wright Anja Pogarcic Joseph Jankovic Laura Marsh Farah Ismail Lawrence Severt Emily Muller Ludy C. Shih Christine Ashton Pinky Agarwal Carey Gonzales Zoltán Mari Becky Dunlop Julie Leegwater‐Kim Caitlin Scopa Ron L. Alterman Steven J. Frucht Laurie J. Ozelius Kristina Simonyan Miodrag Velickovic Ruth H. Walker Joan Bratton Daniel Troung Trong-Tuong Binh Nguyen Cynthia Comella Tracy Waliczek Tanya Harlow S. Gonzales D. Spaëth Fatta B. Nahab Lissette Moreno Tao Xie Joan Young Alberto J. Espay Jaya Mishra Ben Wissel Brian D. Berman Erika Shelton Irene A. Malaty Ramon L. Rodriguez Kyle Rizer Amanda Elers Manuchair Ebadi Jeri Sieren Stephen G. Reich Katherine Holmes Richard L. Barbano Michael Bull Mark S. LeDoux Misty M. Thompson Claudia Testa Virginia Norris D Demers Alison Brashear Charlotte Miller Victor SC Fung Florence Chang Jane M Griffith S. Chouinard Monica Beland Oksana Suchowersky Paul McCann Susan H. Fox Brandon Rothberg Marie Vidailhet Emmanuel Roze Cécilia Bonnet Marta Ruiz Bertrand Degos Jean Michel Mayer Kailash Bhatia Bettina Balint Christine Klein Norbert Brüggemann Sylwia Dankert Johanna Junker Anne Weibach Natividad Stover Ashlee Brooke Rawlins Charles Alder Amy Duffy Stephen Grill Erica Stacy Joel H. Blumin

To determine the frequency of medication use in patients with dystonia enrolled an international biorepository study.In a cross-sectional analysis, we included 2,026 participants at 37 sites United States, Canada, Europe, and Australia through Project 1 Dystonia Coalition, study. The primary aim was to assess classes recommended for treating dystonia, secondary compare characteristics (disease type, age, sex, duration disease, comorbid conditions, severity).Querying database presence any...

10.1212/wnl.0000000000003596 article EN Neurology 2017-01-12

<h3>Objective:</h3> To characterize the clinical and genetic features of cervical dystonia (CD). <h3>Methods:</h3> Participants enrolled in Dystonia Coalition biorepository (NCT01373424) with initial manifestation as CD were included this study (n = 1,000). Data intake demographics, family history, Global Rating Scale. screened for sequence variants (SVs) <i>GNAL</i>, <i>THAP1</i>, Exon 5 <i>TOR1A</i>. <h3>Results:</h3> The majority participants Caucasian (95%) female (75%). mean age at...

10.1212/nxg.0000000000000069 article EN cc-by-nc-nd Neurology Genetics 2016-04-12

Objective To evaluate the relationship between health-related quality of life (HR-QoL) and both physical psychiatric factors in a large, international, multicentre cohort patients with isolated dystonia, Dystonia Coalition. Methods Natural history data from 603 dystonia (median age 57 years (IQR: 48 to 64 years), 67.0% women) were prospectively acquired analysed. HR-QoL (RAND 36-Item Health Survey), severity depressive symptoms, generalised anxiety (Hospital Anxiety Depression Scale) social...

10.1136/jnnp-2020-325193 article EN Journal of Neurology Neurosurgery & Psychiatry 2021-02-09

Abstract Background Pathogenic variants in several genes have been linked to genetic forms of isolated or combined dystonia. The phenotypic and spectrum the frequency pathogenic these not yet fully elucidated, neither patients with dystonia nor other, sometimes co‐occurring movement disorders such as Parkinson's disease (PD). Objectives To screen &gt;2000 PD for rare known dystonia‐causing genes. Methods We screened 1207 from Germany (DysTract consortium), Spain, South Korea, 1036 using a...

10.1002/mds.29693 article EN cc-by-nc-nd Movement Disorders 2024-01-12
Lara M. Lange Kristin Levine Susan H. Fox Connie Marras Nazish Rafique and 95 more Nicole Kuznetsov Dan Vitale Hirotaka Iwaki Katja Lohmann Luca Marsili Alberto J. Espay Peter Bauer Christian Beetz Jessica Martin Stewart A. Factor Lenora A. Higginbotham Honglei Chen Hampton L. Leonard Mike A. Nalls Niccolò E. Mencacci Huw R. Morris Andrew Singleton Christine Klein Cornelis Blauwendraat Zih‐Hua Fang Emilia Gatto Marcelo Kauffman Samson Khachatryan Zaruhi Tavadyan Claire E. Shepherd Julie Hunter Kishore R. Kumar Melina Ellis Miguel E. Rentería Sulev Kõks Alexander Zimprich Artur Francisco Schumacher Schuh Carlos Roberto de Mello Rieder Paula Saffie Awad Vítor Tumas Sarah Camargos Edward A. Fon Oury Monchi Ted Fon Benjamin Pizarro Galleguillos Patricio Olguı́n Marcelo Miranda M. Leonor Bustamante Pedro Chaná Beisha Tang Huifang Shang Jifeng Guo Piu Chan Wei Luo Gonzálo Arboleda Jorge Orozco Marlene Jiménez-Del-Río Álvaro Hernández-Flores Mohamed Salama Walaa A. Kamel Yared Z. Zewde Alexis Brice Jean‐Christophe Corvol Ana Westenberger Eva‐Juliane Vollstedt Harutyun Madoev Joanne Trinh Johanna Junker Anastasia Illarionova Brit Mollenhauer Franziska Hopfner Günter U. Höglinger Manu Sharma Thomas Gasser Sergiu Groppa Albert Akpalu Georgia Xiromerisiou Georgios Hadjigorgiou Efthymios Dadiotis Ioannis E. Dagklis Ioannis Tarnanas Leonidas Stefanis María Stamelou Alex Medina Germaine Hiu-Fai Chan Nelson Yuk-Fai Cheung Nancy Y. Ip Phillip Chan Xiaopu Zhou Asha Kishore Divya KP Pramod Kr. Pal Prashanth Lingappa Kukkle Roopa Rajan Rupam Borgohain Mehri Salari Andrea Quattrone Monica Gagliardi Enza Maria Valente Micol Avenali

Abstract LRRK2 -PD represents the most common form of autosomal dominant Parkinson’s disease. We identified p.L1795F variant in three families and six additional unrelated cases using genetic data from over 50,000 individuals. Carriers with available genotyping shared a haplotype. The clinical presentation resembles other forms. Combined published functional evidence showing strongly enhanced kinase activity, we provide that is pathogenic.

10.1038/s41531-025-00896-2 article EN cc-by npj Parkinson s Disease 2025-03-25

The use of complementary and alternative medicine (CAM) is increasing worldwide, especially by patients with chronic diseases. To date, no data are available about utilization perceived effectiveness CAM in dystonia. A questionnaire survey on costs was completed 180 members the German Dystonia Society, a patient advocate group. In total, 131 dystonia (73%) were current or former users CAM, 55 used addition to botulinum toxin injections, 86 had experience three more methods. options most...

10.1002/mds.10684 article EN Movement Disorders 2003-11-19

To determine predictors of alcohol responsiveness in a large cohort patients with dystonia.A total 2,159 participants dystonia were prospectively enrolled the cross-sectional Dystonia Coalition multicenter study. Patients secondary, combined, or confirmed genetic (total n = 164) unknown (n 737) excluded. answered standardized questionnaire and clinically examined using video protocol Burke-Fahn-Marsden Rating Scale. Alcohol was determined by patients' self-report.A 1,258 isolated (mean age:...

10.1212/wnl.0000000000006551 article EN Neurology 2018-10-19

Until recently, about three-quarters of all monogenic Parkinson's disease (PD) studies were performed in European/White ancestry, thereby severely limiting our insights into genotype-phenotype relationships at global scale. The first systematic approach to embrace PD worldwide, Michael J. Fox Foundation Global Monogenic (MJFF GMPD) Project, contacted authors publications reporting individuals carrying pathogenic variants known PD-causing genes. In contrast, the Genetics Program's (GP2)...

10.1101/2024.03.12.24304154 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2024-03-15

Dystonia is conceptualized as a network disorder involving basal ganglia, thalamus, sensorimotor cortex and the cerebellum. The cerebellum has been implicated in dystonia pathophysiology, but studies testing cerebellar function patients have provided equivocal results. This study aimed to further elucidate motor deficits cervical with special interest role of To this end we investigated learning tasks, that differ their dependence on ganglia functioning. In 18 age matched healthy controls...

10.1038/s41598-021-86513-7 article EN cc-by Scientific Reports 2021-04-01

Abstract The temporal discrimination threshold (TDT) has been established as a biomarker of impaired processing and endophenotype in various forms focal dystonia patients, such cervical dystonia, writer’s cramp or blepharospasm. role TDT musician’s (MD) contrast is less clear with preceding studies reporting inconclusive results. We therefore compared between MD healthy musicians non-musician controls using previously described visual, tactile, visual-tactile paradigm. Additionally, we the...

10.1038/s41598-022-18739-y article EN cc-by Scientific Reports 2022-09-02

Abstract Objective To determine longitudinal predictors of health-related quality life (HR-QoL) in an international multicenter cohort patients with isolated dystonia. Methods Out 603 dystonia prospectively enrolled the Natural History Dystonia Coalition study, 155 were assessed three times within 2 years for HR-QoL, symptoms depression, generalized anxiety disorder (GAD), and social (SAD), as well severity dystonic tremor. In addition, impact botulinum neurotoxin (BoNT) injections on HR-QoL...

10.1007/s00415-023-12022-4 article EN cc-by Journal of Neurology 2023-10-15

Abstract The Monogenic Network of the Global Parkinson’s Genetics Program (GP2) aims to create an efficient infrastructure accelerate identification novel genetic causes disease (PD) and improve our understanding already identified causes, such as reduced penetrance variable clinical expressivity known disease-causing variants. We aim perform short- long-read whole-genome sequencing for up 10,000 patients with parkinsonism.

10.1101/2022.12.01.22282794 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2022-12-05

Introduction: Cerebral palsy (CP) is one of the most common reasons for spastic paresis in children. More than half patients suffer from chronic pain. So far it unknown if pain primarily origin neuropathic ore nociceptive mechanisms. This important therapy. The German Research Network on Neuropathic Pain (DFNS) established a standardised QST protocol encompassing all somatosensory modalities to assess functioning different nerve fibers, lemniscal and extralemniscal system other central...

10.1055/s-0030-1265609 article EN Neuropediatrics 2010-08-01
Coming Soon ...